Literature DB >> 10365003

Glycine toxicity after high-dose i.v. infusion of 1.5% glycine in the mouse.

J Olsson1, R G Hahn.   

Abstract

Glycine 1.5% is the most widely used irrigating fluid during endoscopic procedures. To investigate if glycine toxicity is a mechanism promoting a fatal outcome when the solution is absorbed, we administered glycine 200 or 300 ml kg-1 dissolved in sterile water or normal saline, and also normal saline alone, over 60 min by i.v. infusion to 100 mice under methoxyflurane anaesthesia. Survival rates were 29% after 1.5% glycine, 21% after 1.5% glycine in normal saline, 67% after normal saline and 100% in controls. Both solutions containing glycine induced bradycardia and prolongation of the PQ interval and QRS duration, while only 1.5% glycine increased the water content of the myocardium. These results suggest that glycine promotes bradycardia and death, regardless of whether hyponatraemia or hypo-osmolality is present. We conclude that glycine toxicity is an important factor that increases the risk of administration of an irrigating fluid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365003     DOI: 10.1093/bja/82.2.250

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitis.

Authors:  Dennis P Han; William J O'Brien; Brian Higgins
Journal:  J Ocul Pharmacol Ther       Date:  2011-06-01       Impact factor: 2.671

2.  Glycine and ammonia plasma concentrations during sedation with remifentanil in critically ill patients.

Authors:  Marie-Pierre Bonnet; Vincent Minville; Karim Asehnoune; Delphine Bridoux; Joséphine Poggi-Bach; Jacques Duranteau; Dan Benhamou
Journal:  Intensive Care Med       Date:  2007-03-09       Impact factor: 17.440

3.  Why Omicron Variant of SARS-CoV-2 is Less Fatal?

Authors:  Lipeng Liao; Jiaming Zhang; Yuchuan Wang; Qiuyun Liu
Journal:  Chembiochem       Date:  2022-05-31       Impact factor: 3.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.